Insider · CIK 0001569821
OrbiMed Israel BioFund GP Limited Partnership
Files at HLSQ (BiomX Inc.). First filing May 20, 2024, latest May 20, 2024.
In brief
OrbiMed Israel BioFund GP Limited Partnership files SEC Form 4 as 10% owner and director at HLSQ (BiomX Inc.). Since May 20, 2024, OrbiMed Israel BioFund GP Limited Partnership has reported 0 open-market buys worth $0 and 1 open-market sell worth $9,280, the latest filed on May 20, 2024.
A track record needs three past buys with six months of prices behind them; OrbiMed Israel BioFund GP Limited Partnership has 0, so none is measured yet.
The newest scored trade: sold $9,280 of HLSQ on May 15, 2024, filed May 20, 2024, scored 12 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HLSQ: BiomX Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 12Weak | HLSQsell BiomX Inc. | $9,280 24,344 shares | -0% | +65% from low-50% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2024 | HLSQ BiomX Inc. | XIn-the-money exercise Common Stockindirect: See footnotes | +9,280,408 | $0.24 | $2.3M | 13,797,997 | May 20, 2024 |
| May 15, 2024 | HLSQ BiomX Inc. | SOpen-market sale Common Stockindirect: See footnotes | -24,344 | $0.38 | $9,280 | 13,773,653 | May 20, 2024 |
| May 15, 2024 | HLSQ BiomX Inc. | XIn-the-money exercise Warrants (Right to Buy)derivativeindirect: See footnotes | -9,280,408 | $0.00 | $0 | 0 | May 20, 2024 |
| Mar 15, 2024 | HLSQ BiomX Inc. | POpen-market purchase Series X Preferred Stockderivativeindirect: See footnotes | +4,327 | - | - | 4,327 | Mar 19, 2024 |
| Mar 15, 2024 | HLSQ BiomX Inc. | POpen-market purchase Warrants (Right to Buy)derivativeindirect: See footnotes | +2,163,500 | - | - | 2,163,500 | Mar 19, 2024 |
Questions about OrbiMed Israel BioFund GP Limited Partnership
Answered from the filings on this page, as of the latest one.
Is OrbiMed Israel BioFund GP Limited Partnership buying or selling?
Not in the last 12 months. OrbiMed Israel BioFund GP Limited Partnership's latest open-market trade on SEC Form 4 was sold $9,280 of HLSQ on May 15, 2024.
How did OrbiMed Israel BioFund GP Limited Partnership's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and OrbiMed Israel BioFund GP Limited Partnership has 0.
Where does OrbiMed Israel BioFund GP Limited Partnership file Form 4?
OrbiMed Israel BioFund GP Limited Partnership has filed Form 4 at HLSQ (BiomX Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.